Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3 replacing Revision: v3.5.2, indicating a small update to the page's release labeling.
    Difference
    0.1%
    Check dated 2026-04-30T16:15:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2; no visible study content changes.
    Difference
    0.1%
    Check dated 2026-04-16T09:32:05.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T15:50:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The revision label in the UI was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:29:08.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Minor site-wide update to Revision: v3.4.2 and removal of the government funding status notice; no changes to trial content, enrollment, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T04:50:27.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, with guidance to check cc.nih.gov and opm.gov for updates. The page revision version was updated from 3.4.0 to 3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T03:48:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.